Delta 9 Announces Completion of Acquisition of Three Retail Cannabis Stores in Manitoba

Delta 9 Announces Completion of Acquisition of Three Retail Cannabis Stores in Manitoba WINNIPEG, Manitoba, Sept. 07, 2022 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”) is pleased to announce that on September 6, 2022 it completed a previously announced transaction with 10552763 Canada Corp. (the “Vendor”) … Continue reading Delta 9 Announces Completion of Acquisition of Three Retail Cannabis Stores in Manitoba

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™ Ketamine Patch

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™ Ketamine Patch KETARX™ Ketamine Patch demonstrated extended delivery of ketamine over 40 hours KETARX™ Ketamine Patch offers flexible dosing through increased size, drug load or concentration of ketamine to better align with intramuscular and intravenous administration Initiating clinical studies by the end of Q4-2022 to support … Continue reading PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™ Ketamine Patch

Takeda Canada Partners with the Canadian Institutes of Health Research (CIHR) to Advance Research in Rare Diseases

Takeda Canada Partners with the Canadian Institutes of Health Research (CIHR) to Advance Research in Rare Diseases Takeda Canada and CIHR’s Institute of Genetics have partnered to establish a fellowship program to identify emerging talent and innovation to support advancements in rare disease across Canada. Fellowship program will provide $720,000 to support four (4) research awards. Opportunity … Continue reading Takeda Canada Partners with the Canadian Institutes of Health Research (CIHR) to Advance Research in Rare Diseases

Pharmacy Benefit Managers pilfer millions from health plans that should instead reduce costs for employers and employees  

Pharmacy Benefit Managers pilfer millions from health plans that should instead reduce costs for employers and employees   Katy Talento: ‘Despite the caterwauling from the Health Care Swamp, the only way to pay less for health care is to actually pay less for health care’  WASHINGTON D.C. — Middlemen known as Pharmacy Benefit Managers (PBMs) claim to get volume … Continue reading Pharmacy Benefit Managers pilfer millions from health plans that should instead reduce costs for employers and employees  

Dr. Sultan Ahmad, Chief Business Officer, Paraza Pharma Inc.

Dr. Sultan Ahmad, Chief Business Officer, Paraza Pharma Inc. MONTREAL, Sept. 6, 2022 /CNW/ – Paraza Pharma Inc., a fully integrated drug discovery organization passionately committed to contributing to the life sciences sector today announced the appointment of Dr. Sultan Ahmad as Chief Business Officer reporting to Dr. Arshad Siddiqui, founder and CEO of Paraza Pharma. “We … Continue reading Dr. Sultan Ahmad, Chief Business Officer, Paraza Pharma Inc.